info@biomedres.us   +1 (720) 414-3554   600 Third Avenue, 2nd floor, New York - 10016, USA
ISSN: 2574 -1241

Review ArticleOpen Access

Corneal cross-linking Procedure in Progressive Keratoconus Treatment

Volume 2 - Issue 3

Arleta Waszczykowska*

  • Author Information Open or Close
    • Department of Ophthalmology and Vision Rehabilitation, Poland

    *Corresponding author: Arleta Waszczykowska, Department of Ophthalmology and Vision Rehabilitation, Medical University of Lodz, Zeromskiego 113, 90-549 Lodz, Poland. Tel: 48426393634;; Email: arletawaszczykowska@interia.pl

Received: February 01, 2018;   Published: February 12, 2018

DOI: 10.26717/BJSTR.2018.02.000754

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Keratoconusis a progressiveeye disease, whichdiscloses in adolescence and usuallystabilizes in thefourthorfifthdecadeoflife. Theprogressivethinningofcorneal stroma in which the cornea has a conical shapeleads to high irregular a stigmatism and consequently to a significantvisualacuitydecrease. Anymethod to curethediseasehas beendeveloped up to thisday. Corneal collagen cross-linking (CXL) is the first treatment that halts the progression of keratoconus. Cross-linkingconducted in the early stages of keratoconus allows to stop cornealchangesduring early grade, easier to opticalcorrection. From the times of “Dresden Protocol” until now, multiple variations of the standard procedure technique have been introduced and consistent improvement is still being searched for.Not onlydoesthe study presenttheclassicalmethodof CXL, acceleratedand transepithelial CXL modifications, but thelatestresearchabouttheireffectiveness as well.

Keywords: Corneal cross-linking; CXLl; Accelerated cross-linking; High irradiance; Transepithelial cross-linking; Keratoconus

Abstract| Introduction| References|